GENE ONLINE|News &
Opinion
Blog

Monoclonal Antibody
Licensing Monoclonal Antibody
China’s InnoCare, Incyte Enter Collaboration And License Deal for Monoclonal Antibody in Greater China
2021-08-18
COVID-19 Monoclonal Antibody
GSK, Vir Ink Deal with Government of Singapore to Supply COVID-19 Drug Sotrovimab
2021-07-03
COVID-19 Monoclonal Antibody
Monoclonal Antibodies for COVID-19: AstraZeneca and Regeneron’s Therapies Endure Contrasting Fortunes
2021-06-16
R&D Atopic Dermatitis
Amgen, Kyowa Kirin Renew Long-Standing Partnership to Promote Atopic Dermatitis Therapy
2021-06-02
R&D Combination Therapy
Xilio Collaborates With Merck to Evaluate Combo of CTLA-4 and PD-1 Blockers Against Solid Tumors
2021-05-26
R&D
Study Shows Bayer’s Aliqopa, Rituximab Combo Improves Survival of Relapsed Lymphoma Patients
2021-04-10
R&D USAG-1
A Novel Antibody Therapy to Rescue Congenital Teeth Defects
2021-04-04
In-Depth
Antibody Drug Conjugates: The Next Big Thing in Cancer Therapy?
2021-03-20
R&D Alzheimer's Disease
Lilly’s Positive Data for Alzheimer’s Drug Bodes Well for Candidates Rooted in Amyloid Hypothesis
2021-03-14
Trials & Approvals PD-1 Inhibitor
FDA Okay of Regeneron’s PD-1 Inhibitor Marks Entry of First Immunotherapy for Advanced Basal Cell Carcinoma
2021-02-12
Trials & Approvals Monoclonal Antibody
AZ’s Immune Checkpoint Inhibitor Flunks Head and Neck Cancer Trial
2021-02-10
Trials & Approvals
Vir Biotech’s Investigational Antibody Therapy Shows Promise in 8-Patient Phase 1 HBV Trial
2021-01-27
Trials & Approvals
Lilly’s Donanemab Aces Phase 2 Trial, Slows Clinical Decline in Alzheimer’s Patients
2021-01-15
Trials & Approvals HER2
Roche Bags EU Nod for a Novel Delivery Method in Breast Cancer Treatment
2020-12-25
COVID-19 Antibody Cocktail
COVID-19: After Lilly, Regeneron Bags EUA for its Antibody Therapy
2020-11-24
1 2 3 4 … 6
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top